Acegastrodine is used in pharmaceutical research for its potential neuroprotective and anti-inflammatory properties. It has been investigated for its role in supporting cognitive function and alleviating symptoms associated with neurological disorders. The compound may modulate pathways involved in oxidative stress, making it a candidate for development in treatments targeting neurodegenerative conditions. Additionally, it has shown interest in traditional medicine applications, particularly in formulations aimed at improving circulation and reducing nervous system fatigue. Research is ongoing to determine its efficacy and mechanisms in clinical settings.